H. Ylipahkala

Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.

H. Väänänen, J. Halleen, S. Tiitinen, 2006, Clinical laboratory.

Serum Tartrate-Resistant Acid Phosphatase 5b, but not 5a, Correlates with Other Markers of Bone Turnover and Bone Mineral Density

H. Suominen, J. Heikkinen, H. Väänänen, 2002, Calcified Tissue International.

Intracellular Machinery for Matrix Degradation in Bone‐Resorbing Osteoclasts

P. Vihko, H. Väänänen, J. Halleen, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Tartrate-resistant acid phosphatase 5B circulates in human serum in complex with alpha2-macroglobulin and calcium.

P. Vihko, H. Väänänen, J. Halleen, 2003, Biochemical and biophysical research communications.

Improved methods for testing antiresorptive compounds in human osteoclast cultures

H. Väänänen, J. Rissanen, J. Halleen, 2008, Journal of Bone and Mineral Metabolism.

Effects of proteolysis and reduction on phosphatase and ROS-generating activity of human tartrate-resistant acid phosphatase.

O. Mäentausta, S. Hamilton, H. Väänänen, 2006, Archives of biochemistry and biophysics.

Macrophages overexpressing tartrate-resistant acid phosphatase show altered profile of free radical production and enhanced capacity of bacterial killing.

D. Hume, A. Cassady, H. Väänänen, 2005, Biochemical and biophysical research communications.

Release of Intact and Fragmented Osteocalcin Molecules from Bone Matrix during Bone Resorption in Vitro*

K. Pettersson, T. Hentunen, H. Väänänen, 2004, Journal of Biological Chemistry.

Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment.

Sulin Cheng, A. Nenonen, K. Uusi-Rasi, 2008, Clinical laboratory.